Article
In a study comparing biochemical failure rates of popular treatments for localized prostate cancer, low-dose external beam radiotherapy showed the highest failure rate.
NDA submitted for 3-month formulation of leuprolide mesylate for advanced prostate cancer
Key updates from the AUA/ASRM male infertility guideline amendment
PSMA PET/CT can reveal prostate cancer recurrences before biochemical criteria met
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
Vaginal estrogen for GSM not associated with major adverse cardiovascular events
FDA approves oral sulopenem for uncomplicated urinary tract infection